American medical companies to open R&D centres in Finland

Fluence Therapeutics and FMI Medical Systems discovered opportunities in Finland via the BioFinland Technology Bridge Program between Akron and Helsinki.

FMI Medical Systems is a biomedical company that has developed a portable ultra-high resolution diagnostic imaging machine for the early detection and monitoring of cancer, cardiovascular disease, neurodegenerative disorders, breast cancer, and bone infections. FMI is planning to hire a 3-4 person sales and marketing team as well as more than 10 researchers in Finland. According to Pia Westerling, chair of FMI’s Finnish company, Finland was selected as a location thanks to its proximity to European and Russian markets, well-functioning bureaucracy, strong networks and good science parks.

Both companies are based in Akron, Ohio, and became aware of the opportunities offered by Finland through cooperation with Tekes – Finnish Funding Agency for Technology and Innovation, and the BioFinland Technology Bridge Program which is a collaborative initiative between the City of Akron, the Akron Global Business Accelerator and the Helsinki Business and Science Park, and the consulting company Radvisor Oy.

Sources: Kauppalehti, City of Akron, Medcity news